Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Johnson Pharmacare
Join Channel
Consolidated Standalone

Johnson Pharmacare

₹1.2 0 | 4.5%

Market Cap ₹63 Cr.

Stock P/E -230.0

P/B 1.1

Current Price ₹1.2

Book Value ₹ 1

Face Value 1

52W High ₹1.4

Dividend Yield 0%

52W Low ₹ 0.5

Edit Ratio

Johnson Pharmacare Research see more...

Overview Inc. Year: 1994Industry: Trading

Johnson Pharmacare Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Johnson Pharmacare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 2 0 0 3 0 0 0 0 0 0
Other Income 0 0 0 0 0 -2 0 0 0 0
Total Income 2 0 0 3 0 -2 0 0 0 0
Total Expenditure 1 0 0 2 0 0 0 0 0 0
Operating Profit 0 -0 -0 0 -0 -2 -0 -0 -0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 -0 0 -0 -2 -0 -0 -0 -0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 -0 -0 0 -0 -2 -0 -0 -0 -0
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 -0 -0 0 -0 -2 -0 -0 -0 -0
Adjusted Earnings Per Share 0 -0 -0 0 -0 -0 -0 -0 0 -0

Johnson Pharmacare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 159 1791 0 0 0 0 1 0 1 3 3 0
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Total Income 159 1791 0 0 0 0 1 0 1 3 3 0
Total Expenditure 159 1791 0 0 0 0 1 0 1 3 4 0
Operating Profit -0 -0 -0 -0 -0 -0 -0 -0 0 0 -1 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses -0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 -0 -0 -0 -0 -0 -0 0 0 -1 0
Provision for Tax -0 -0 0 0 0 0 0 0 0 0 -0 0
Profit After Tax -0 -0 -0 -0 -0 -0 -0 -0 0 0 -1 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 -0 -0 -0 -0 -0 -0 -0 0 0 -1 0
Adjusted Earnings Per Share -0 -0 -0 -0 -0 -0 -0 -0 0 0 -0 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% -33%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 125% 72% 33% -15%
ROE Average -2% -1% -0% -0%
ROCE Average -2% -1% -0% -0%

Johnson Pharmacare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 59 59 58 58 58 58 58 58 58 58 57
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 1 1 1 1 2 2 1 1 1 2
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Total Current Liabilities 0 1 0 0 0 0 0 0 1 1 1
Total Liabilities 59 60 60 59 59 60 60 59 59 60 60
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 24 34 56 37 55 56 55 54 54 59 60
Total Current Assets 36 26 4 22 4 4 5 5 6 1 0
Total Assets 59 60 60 59 59 60 60 59 59 60 60

Johnson Pharmacare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 1 4 8 -11 11 -1 -1 0 -0 5 -0
Cash Flow from Investing Activities -13 -4 -10 11 -11 -0 1 1 0 -5 0
Cash Flow from Financing Activities 12 1 2 0 0 1 0 -1 0 -0 0
Net Cash Inflow / Outflow 0 -0 0 0 0 -0 -0 -0 -0 -0 -0
Closing Cash & Cash Equivalent 0 0 0 0 0 0 0 0 0 0 0

Johnson Pharmacare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0 -0 -0 -0 -0 -0 -0 -0 0 0 -0.02
CEPS(Rs) -0 -0 -0 -0 -0 -0 -0 -0 0 0 -0.02
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 1.07 1.06 1.06 1.06 1.06 1.06 1.06 1.06 1.06 0.96 1.04
Core EBITDA Margin(%) -0.09 -0 0 0 0 0 -1.19 0 0.21 4.13 -52.57
EBIT Margin(%) -0.08 -0 0 0 0 0 -1.19 0 0.21 4.13 -52.57
Pre Tax Margin(%) -0.08 -0 0 0 0 0 -1.19 0 0.21 4.12 -52.61
PAT Margin (%) -0.08 -0 0 0 0 0 -1.19 0 0.15 2.96 -51.11
Cash Profit Margin (%) -0.07 -0 0 0 0 0 -1.19 0 0.15 2.96 -51.11
ROA(%) -0.22 -0.14 -0.12 -0.21 -0.13 -0.11 -0.02 -0.15 0 0.16 -2.16
ROE(%) -0.22 -0.14 -0.13 -0.21 -0.13 -0.11 -0.02 -0.16 0 0.17 -2.24
ROCE(%) -0.22 -0.14 -0.12 -0.21 -0.05 -0.11 -0.02 -0.15 0 0.23 -2.26
Receivable days 32.53 2.08 0 0 0 0 365 0 624.34 152.68 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0.08 0.05 0 0 0 0 0 0 182.5 0 0
PER(x) 0 0 0 0 0 0 0 0 0 733.71 0
Price/Book(x) 4.03 7.16 1.14 0.41 0.42 0 0.24 0.1 0.24 1.22 0.42
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 1.49 0.23 0 0 0 0 16.73 0 19.02 21.92 10.11
EV/Core EBITDA(x) -2355.32 -5410.4 -909.22 -194.18 -774.2 -822.31 -1407.45 -67.51 9109.98 530.92 -19.23
Net Sales Growth(%) 1728.25 1025.89 -100 0 0 0 0 -100 0 329.37 -22.56
EBIT Growth(%) -54.09 35.55 12.85 -70 74.2 -93.32 82.49 -739.55 101.73 8388.78 -1086.27
PAT Growth(%) -57.63 35.61 11.21 -70.24 40.06 17.01 82.5 -739.55 101.28 8135.39 -1435.47
EPS Growth(%) -57.63 35.61 11.21 -70.24 40.06 16.97 82.5 -741.34 100 0 -1570.27
Debt/Equity(x) 0.01 0.02 0.01 0.01 0.01 0.03 0.03 0.01 0.01 0.01 0.03
Current Ratio(x) 576.41 27.83 8.99 485.33 62.95 4257.88 5142 4858.39 8.6 0.96 0
Quick Ratio(x) 576.41 27.83 8.99 485.33 62.95 4257.88 5142 4858.39 8.6 0.96 0
Interest Cover(x) -1072.39 0 -725.12 -360 -70.8 -4558.94 0 0 0 449 -1660.63
Total Debt/Mcap(x) 0 0 0.01 0.03 0.02 0 0.12 0.11 0.05 0.01 0.08

Johnson Pharmacare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 0 0 0 0 0 0 0 0 0 0
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 100 100 100 100 100 100 100 100 100 100
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of -1% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Johnson Pharmacare News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!